Sort
11,323 grants matching “glioblastoma”
Cancer as a Complex Adaptive System
$500,000Robert A Gatenby · H. Lee Moffitt Cancer Ctr & Res Inst · U54 · FY2020 · CA
Genotype and Metabolic Phenotype in Glioblastoma
$500,000Elizabeth A Maher · Ut Southwestern Medical Center · RC1 · FY2009 · NS
Genotype and Metabolic Phenotype in Glioblastoma
$500,000Elizabeth A Maher · Ut Southwestern Medical Center · RC1 · FY2010 · NS
Quantitative Biomarker Imaging for Early Therapy Response Assessment in Cancer
$500,000James M Mountz · University Of Pittsburgh At Pittsburgh · U01 · FY2009 · CA
Phase 2/3 Study of Toca 511-Toca FC vs SOC in Recurrent GBM-AA IND 14173 9Jul2015
$500,000Sophie Visonneau · Tocagen, Inc. · R01 · FY2018 · FD
GOALI: Magnetoelectric Nanoparticles As Multi-Field Controlled Devices for Activation of Brain Circuitry
$500,000Sakhrat Khizroev · University Of Miami · · FY2022 · ENG
Gene Expression Patterns in Human Tumors Identified Using Transcript Sequencing
$500,000Charles M Perou · Univ Of North Carolina Chapel Hill · U24 · FY2014 · CA
SPORE in Brain Cancer
$500,000Sloan-Kettering Institute For Cancer Res · P20 · FY2003 · CA
Ph2a Study of DNX-2401 for Treatment of Glioblastoma (GBM) IND13,678 (12/23/2014)
$500,000Matteo G Levisetti · Dnatrix, Inc. · R01 · FY2019 · FD
Ph2a Study of DNX-2401 for Treatment of Glioblastoma (GBM) IND13,678 (12/23/2014)
$500,000Frank Tufaro · Dnatrix, Inc. · R01 · FY2018 · FD
SPORE in Brain Cancer
$500,000Sloan-Kettering Institute For Cancer Res · P20 · FY2002 · CA
Defining cellular states of quiescence in human brain tumors
$499,981Patrick Paddison · Fred Hutchinson Cancer Center · R01 · FY2024 · NS
Targeted Photoactivable Nanocells: Image-based Drug Delivery and Dosimetry in GBM
$499,924Tayyaba Hasan · Massachusetts General Hospital · R01 · FY2012 · CA
Mechanisms of Chemo/Radioresistance in Human Gliomas
$499,834John J Laterra · Hugo W. Moser Res Inst Kennedy Krieger · R01 · FY2009 · NS
Hydrogen sulfide functions as a tumor suppressor in glioblastoma
$499,693Christopher Michael Hine · Cleveland Clinic Lerner Com-Cwru · R01 · FY2024 · NS
Perivascular tissue models to overcome MGMT-mediated temozolomide resistance in glioblastoma
$499,601Brendan A. Harley · University Of Illinois At Urbana-Champaign · R01 · FY2025 · CA
Evaluating microtubule binding as a potential imaging biomarker for Alzheimer's disease
$499,595Kiran Solingapuram Sai · Wake Forest University Health Sciences · R01 · FY2020 · AG
Molecular Imaging of Resident Cardiac Stem Cells
$499,544Joseph C Wu · Stanford University · RC1 · FY2010 · HL
Brain tumors with regulatory T-cells treated with EGFRvIII-specific T-cells
$499,514John H Sampson · Duke University · R01 · FY2016 · CA
Targeted drug delivery system to overcome blood-brain barrier and therapeutic resistance to current standard of care in Glioblastoma
$499,464Meser M. Ali · Henry Ford Health System · R01 · FY2023 · CA
Molecular Profiling of Patients Undergoing Radiotherapy
$499,134Kevin Camphausen · Division Of Clinical Sciences - Nci · ZIA · FY2018 · CA
The USC-JHU Cancer Epigenome Characterization Center
$498,892Daniel Joseph Weisenberger · University Of Southern California · U24 · FY2014 · CA
Understanding EGF receptor activation by growth factors and oncogenic mutations
$498,622Mark A. Lemmon · Yale University · R01 · FY2015 · CA
The role of Tumor associated macrophages in glioblastoma
$498,283Dolores Hambardzumyan · Icahn School Of Medicine At Mount Sinai · R01 · FY2020 · NS
The role of Tumor associated macrophages in glioblastoma
$498,283Dolores Hambardzumyan · Icahn School Of Medicine At Mount Sinai · R01 · FY2021 · NS